Long-Term CD4+ Cell Count in Response to Combination Antiretroviral Therapy

Abstract

ObjectiveThere is a continuous debate on how to adequately evaluate long-term CD4+ cell count in response to combination antiretroviral therapy (ART) among human immunodeficiency virus (HIV)-infected individuals. Our study evaluated the long-term CD4+ cell count response (up to ten years) after initiation of ART and described the differences in the CD4+ cell count response stratified by pretreatment CD4+ cell count, and other socio-demographic, behavioral, and clinical factors.MethodsThe study population included patients starting ART in the clinical cohorts of Rio de Janeiro, Brazil, and Baltimore, United States. Inverse probability of censoring weighting was used to estimate mean annual CD4+ cell counts while adjusting for choice of initial ART regimen, ART discontinuation and losses-to-follow-up.ResultsFrom 1997 to 2011, 3116 individuals started ART; preferred initial regimen was NNRTI-based (63%). The median follow-up time was 5 years, 10% of the individuals had nine or more years of follow-up. Observed CD4+ cell counts increased throughout the ten years of follow-up. Weighted results, in contrast, increased up to year four and plateaued thereafter with 50% of the population reaching CD4+ cell counts of 449/μL or more. Out of all stratification variables considered, only individuals with pre-treatment CD4+ cell counts ≥350/μL showed increasing CD4+ cell counts over time with 76% surpassing the CD4+ cell count >500/μL threshold at year ten.ConclusionThe present study corroborates the growing body of knowledge advocating early start of ART by showing that only patients who start ART early fully recover to normal CD4+ cell counts.

Methylome-wide Analysis of Chronic HIV Infection Reveals Five-Year Increase in Biological Age and Epigenetic Targeting of HLA

“…The lack of an increase of age advancement with disease duration seems to contradict alternative views that HIV-mediated aging occurs through cumulative effects of latent virus (Appay and Rowland-Jones, 2002) or chronic therapeutic intervention (Torres and Lewis, 2014). We did however observe less variation in age advancement within the chronically infected HIV+ individuals (Figure 2F, P < 0.002, Bartlett’s test relative to recently infected group), perhaps reflecting the comparative stability of infection and immune response on long-term cART therapy (Luz et al, 2014; Rosenblatt et al, 2005). …”

Estimation of the HIV Incidence and of the Number of People Living With HIV/AIDS in Brazil, 2012

“…Many studies have pointed out the need of early detection of HIV [44,45]. The current technological advances allow through rapid tests to find in a few minutes the HIV status of an individual [46].…”

Pattern and predictors of cluster of differentiation 4 (CD4) cell count recovery among cohorts of human immunodeficiency virus (HIV)-infected patients on antiretroviral therapy in Hawassa University Referral Hospital

“…We used a data collection tool that was previously described, and that was developed using the federal ministry of health HIV care/ART entry and follow-up forms used in the ART clinic of the Hospital (Naftalin et al, 2015;Mutimura et al, 2015;Luz et al, 2014;Kanters et al, 2014;Calmy et al, 2012;Boulassel et al, 2012;Wright et al, 2011;Waters et al, 2011;Okulicz et al, 2010;McKinnon et al, 2010;Lok et al, 2010). Data sources included the pre-ART registration, lab requests, monthly cohort and follow up forms, the ART intake form, the patients' card, and the death certificate.…”